Haotian Wu1, Allan C Just2, Elena Colicino2, Antonia M Calafat3, Emily Oken4, Joseph M Braun5, Nia McRae2, Alejandra Cantoral6, Ivan Pantic7, María Luisa Pizano-Zárate8, Mary Cruz Tolentino6, Robert O Wright9, Martha M Téllez-Rojo10, Andrea A Baccarelli11, Andrea L Deierlein12. 1. Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, NY, USA. Electronic address: hw2694@cumc.columbia.edu. 2. Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, NY, USA. 3. National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA, USA. 4. Division of Chronic Disease Research Across the Lifecourse, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA. 5. Department of Epidemiology, School of Public Health, Brown University, Providence, RI, USA. 6. Department of Health, Universidad Iberoamericana, Mexico City, Mexico. 7. Department of Developmental Neurobiology, National Institute of Perinatology, Mexico City, Mexico. 8. Division of Community Interventions Research, National Institute of Perinatology, Mexico City, Mexico; UMF 4, 37 South Delegation of the Federal District, Mexican Social Security System (IMSS), Mexico City, Mexico. 9. Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, NY, USA; Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY, USA. 10. Center for Nutrition and Health Research, National Institute of Public Health, Ministry of Health, Cuernavaca, Mexico. 11. Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, NY, USA. 12. School of Global Public Health, New York University, NY, USA.
Abstract
BACKGROUND: Pregnancy induces numerous cardiovascular and metabolic changes. Alterations in these sensitive processes may precipitate long-term post-delivery health consequences. Studies have reported associations between phthalates and metabolic complications of pregnancy, but no study has investigated metabolic outcomes beyond pregnancy. OBJECTIVES: To examine associations of exposure to phthalates during pregnancy with post-delivery metabolic health. DESIGN: We quantified 15 urinary phthalate biomarker concentrations during the second and third trimesters among 618 pregnant women from Mexico City. Maternal metabolic health biomarkers included fasting blood measures of glycemia [glucose, insulin, Homeostatic Model Assessment of Insulin Resistance [HOMA-IR], % hemoglobin A1c (HbA1c%)] and lipids (total, high-density lipoprotein (HDL), low-density lipoprotein (LDL) cholesterol, triglycerides), at 4-5 and 6-8 years post-delivery. To estimate the influence of the phthalates mixture, we used Bayesian weighted quantile sum regression and Bayesian kernel machine regression; for individual biomarkers, we used linear mixed models. RESULTS: As a mixture, higher urinary phthalate biomarker concentrations during pregnancy were associated with post-delivery concentrations of plasma glucose (interquartile range [IQR] difference: 0.13 SD, 95%CrI: 0.05, 0.20), plasma insulin (IQR difference: 0.06 SD, 95%CrI: -0.02, 0.14), HOMA-IR (IQR difference: 0.08 SD, 95% CrI: 0.01, 0.16), and HbA1c% (IQR difference: 0.15 SD, 95%CrI: 0.05, 0.24). Associations were primarily driven by mono-2-ethyl-5-carboxypentyl terephthalate (MECPTP) and the sum of dibutyl phthalate biomarkers (∑DBP). The phthalates mixture was associated with lower HDL (IQR difference: -0.08 SD, 95%CrI: -0.16, -0.01), driven by ∑DBP and monoethyl phthalate (MEP), and higher triglyceride levels (IQR difference: 0.15 SD, 95%CrI: 0.08, 0.22), driven by MECPTP and MEP. The overall mixture was not associated with total cholesterol and LDL. However, ∑DBP and MEP were associated with lower and higher total cholesterol, respectively, and MECPTP and ∑DBP were associated with lower LDL. CONCLUSIONS: Phthalate exposure during pregnancy is associated with adverse long-term changes in maternal metabolic health. A better understanding of timing of the exact biological changes and their implications on metabolic disease risk is needed.
BACKGROUND: Pregnancy induces numerous cardiovascular and metabolic changes. Alterations in these sensitive processes may precipitate long-term post-delivery health consequences. Studies have reported associations between phthalates and metabolic complications of pregnancy, but no study has investigated metabolic outcomes beyond pregnancy. OBJECTIVES: To examine associations of exposure to phthalates during pregnancy with post-delivery metabolic health. DESIGN: We quantified 15 urinary phthalate biomarker concentrations during the second and third trimesters among 618 pregnant women from Mexico City. Maternal metabolic health biomarkers included fasting blood measures of glycemia [glucose, insulin, Homeostatic Model Assessment of Insulin Resistance [HOMA-IR], % hemoglobin A1c (HbA1c%)] and lipids (total, high-density lipoprotein (HDL), low-density lipoprotein (LDL) cholesterol, triglycerides), at 4-5 and 6-8 years post-delivery. To estimate the influence of the phthalates mixture, we used Bayesian weighted quantile sum regression and Bayesian kernel machine regression; for individual biomarkers, we used linear mixed models. RESULTS: As a mixture, higher urinary phthalate biomarker concentrations during pregnancy were associated with post-delivery concentrations of plasma glucose (interquartile range [IQR] difference: 0.13 SD, 95%CrI: 0.05, 0.20), plasma insulin (IQR difference: 0.06 SD, 95%CrI: -0.02, 0.14), HOMA-IR (IQR difference: 0.08 SD, 95% CrI: 0.01, 0.16), and HbA1c% (IQR difference: 0.15 SD, 95%CrI: 0.05, 0.24). Associations were primarily driven by mono-2-ethyl-5-carboxypentyl terephthalate (MECPTP) and the sum of dibutyl phthalate biomarkers (∑DBP). The phthalates mixture was associated with lower HDL (IQR difference: -0.08 SD, 95%CrI: -0.16, -0.01), driven by ∑DBP and monoethyl phthalate (MEP), and higher triglyceride levels (IQR difference: 0.15 SD, 95%CrI: 0.08, 0.22), driven by MECPTP and MEP. The overall mixture was not associated with total cholesterol and LDL. However, ∑DBP and MEP were associated with lower and higher total cholesterol, respectively, and MECPTP and ∑DBP were associated with lower LDL. CONCLUSIONS: Phthalate exposure during pregnancy is associated with adverse long-term changes in maternal metabolic health. A better understanding of timing of the exact biological changes and their implications on metabolic disease risk is needed.
Authors: Nudrat Noor; Kelly K Ferguson; John D Meeker; Ellen W Seely; Russ Hauser; Tamarra James-Todd; Thomas F McElrath Journal: Int J Hyg Environ Health Date: 2019-01-28 Impact factor: 5.840
Authors: A C Gore; V A Chappell; S E Fenton; J A Flaws; A Nadal; G S Prins; J Toppari; R T Zoeller Journal: Endocr Rev Date: 2015-11-06 Impact factor: 19.871
Authors: Jennifer F Bobb; Linda Valeri; Birgit Claus Henn; David C Christiani; Robert O Wright; Maitreyi Mazumdar; John J Godleski; Brent A Coull Journal: Biostatistics Date: 2014-12-22 Impact factor: 5.279
Authors: Alejandra Martínez-Ibarra; Luis Daniel Martínez-Razo; Edgar Ricardo Vázquez-Martínez; Nayeli Martínez-Cruz; Rogelio Flores-Ramírez; Elizabeth García-Gómez; Marisol López-López; Carlos Ortega-González; Ignacio Camacho-Arroyo; Marco Cerbón Journal: Int J Mol Sci Date: 2019-07-07 Impact factor: 5.923
Authors: Lidia Mínguez-Alarcón; Paige L Williams; Tamarra James-Todd; Irene Souter; Jennifer B Ford; Kathryn M Rexrode; Antonia M Calafat; Russ Hauser; Jorge E Chavarro Journal: Toxics Date: 2022-05-28
Authors: Andrea L Deierlein; Alexis R Grayon; Xiaotong Zhu; Yanwen Sun; Xun Liu; Kaelyn Kohlasch; Cheryl R Stein Journal: Int J Environ Res Public Health Date: 2022-05-06 Impact factor: 4.614